{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:55:31Z","timestamp":1776329731016,"version":"3.50.1"},"reference-count":27,"publisher":"Baskent University","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.6002\/ect.2022.0159","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T07:54:24Z","timestamp":1664351664000},"page":"817-825","source":"Crossref","is-referenced-by-count":0,"title":["Prophylactic Recombinant Factor VIIa for Preventing Massive Transfusion During Orthotopic Liver Transplantation"],"prefix":"10.6002","volume":"20","author":[{"given":"Muyue","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Promise","family":"Ariyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke","family":"Perlstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asad","family":"Latif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William T.","family":"Merritt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Philosophe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliaksei","family":"Pustavoitau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4021","reference":[{"key":"ref0","unstructured":"References"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"1. Cleland S, Corredor C, Ye JJ, Srinivas C, McCluskey SA. Massive haemorrhage in liver transplantation: Consequences, prediction and management. World J Transplant. 2016;6(2):291-305. doi:10.5500\/wjt.v6.i2.291","DOI":"10.5500\/wjt.v6.i2.291"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"2. Gurusamy KS, Pissanou T, Pikhart H, Vaughan J, Burroughs AK, Davidson BR. Methods to decrease blood loss and transfusion requirements for liver transplantation. Cochrane Database Syst Rev. 2011;10.1002\/14651858.CD009052.pub2(12):CD009052. doi:10.1002\/14651858.CD009052.pub2","DOI":"10.1002\/14651858.CD009052.pub2"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"3. Biancofiore G, Blasi A, De Boer MT, et al. Perioperative hemostatic management in the cirrhotic patient: a position paper on behalf of the Liver Intensive Care Group of Europe (LICAGE). Minerva Anestesiol. 2019;85(7):782-798. doi:10.23736\/S0375-9393.19.13468-2","DOI":"10.23736\/S0375-9393.19.13468-2"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"4. Chow JH, Lee K, Abuelkasem E, Udekwu OR, Tanaka KA. Coagulation management during liver transplantation: use of fibrinogen concentrate, recombinant activated factor VII, prothrombin complex concentrate, and antifibrinolytics. Semin Cardiothorac Vasc Anesth. 2018;22(2):164-173. doi:10.1177\/1089253217739689","DOI":"10.1177\/1089253217739689"},{"key":"ref5","unstructured":"5. Allen GA, Hoffman M, Roberts HR, Monroe DM, 3rd. Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage. Can J Anaesth. 2002;49(10):S7-S14."},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"6. Meijer K, Hendriks HG, De Wolf JT, et al. Recombinant factor VIIa in orthotopic liver transplantation: influence on parameters of coagulation and fibrinolysis. Blood Coagul Fibrinolysis. 2003;14(2):169-174. doi:10.1097\/01.mbc.0000046194.72384.99","DOI":"10.1097\/00001721-200302000-00008"},{"key":"ref7","unstructured":"7. Novo Nordisk Inc. NovoSeven\u00ae RT, Coagulation Factor VIIa, recombinant. https:\/\/www.novomedlink.com\/rare-bleeding-disorders\/products\/treatments\/novosevenrt.html"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"8. Chavez-Tapia NC, Alfaro-Lara R, Tellez-Avila F, et al. Prophylactic activated recombinant factor VII in liver resection and liver transplantation: systematic review and meta-analysis. PLoS One. 2011;6(7):e22581. doi:10.1371\/journal.pone.0022581","DOI":"10.1371\/journal.pone.0022581"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"9. Yank V, Tuohy CV, Logan AC, et al. Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Ann Intern Med. 2011;154(8):529-540. doi:10.7326\/0003-4819-154-8-201104190-00004","DOI":"10.7326\/0003-4819-154-8-201104190-00004"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"10. Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev. 2012;(3):CD005011. doi:10.1002\/14651858.CD005011.pub4","DOI":"10.1002\/14651858.CD005011.pub4"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"11. Scheffert JL, Taber DJ, Pilch NA, McGillicuddy JW, Baliga PK, Chavin KD. Timing of factor VIIa in liver transplantation impacts cost and clinical outcomes. Pharmacotherapy. 2013;33(5):483-488. doi:10.1002\/phar.1230","DOI":"10.1002\/phar.1230"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"12. Niemann CU, Behrends M, Quan D, et al. Recombinant factor VIIa reduces transfusion requirements in liver transplant patients with high MELD scores. Transfus Med. 2006;16(2):93-100. doi:10.1111\/j.1365-3148.2006.00653.x","DOI":"10.1111\/j.1365-3148.2006.00653.x"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"13. Catalano G, Tandoi F, Mazza E, et al. Simultaneous liver-kidney transplantation in adults: a single-center experience comparing results with isolated liver transplantation. Transplant Proc. 2015;47(7):2156-2158. doi:10.1016\/j.transproceed.2014.11.073","DOI":"10.1016\/j.transproceed.2014.11.073"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"14. Pustavoitau A, Lesley M, Ariyo P, et al. Predictive modeling of massive transfusion requirements during liver transplantation and its potential to reduce utilization of blood bank resources. Anesth Analg. 2017;124(5):1644-1652. doi:10.1213\/ANE.0000000000001994","DOI":"10.1213\/ANE.0000000000001994"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"15. Pustavoitau A, Rizkalla NA, Perlstein B, et al. Validation of predictive models identifying patients at risk for massive transfusion during liver transplantation and their potential impact on blood bank resource utilization. Transfusion. 2020;60(11):2565-2580. doi:10.1111\/trf.16019","DOI":"10.1111\/trf.16019"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"16. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44(1):217-231. doi:10.1016\/j.jhep.2005.10.013","DOI":"10.1016\/j.jhep.2005.10.013"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"17. Wedd J, Bambha KM, Stotts M, et al. Stage of cirrhosis predicts the risk of liver-related death in patients with low Model for End-Stage Liver Disease scores and cirrhosis awaiting liver transplantation. Liver Transpl. 2014;20(10):1193-1201. doi:10.1002\/lt.23929","DOI":"10.1002\/lt.23929"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"18. Tzakis A, Todo S, Starzl TE. Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg. 1989;210(5):649-652. doi:10.1097\/00000658-198911000-00013","DOI":"10.1097\/00000658-198911000-00013"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"19. Planinsic RM, van der Meer J, Testa G, et al. Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl. 2005;11(8):895-900. doi:10.1002\/lt.20458","DOI":"10.1002\/lt.20458"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"20. De Gasperi A, Baudo F, De Carlis L. Recombinant FVII in orthotopic liver transplantation (OLT): a preliminary single centre experience. Intensive Care Med. 2005;31(2):315-316. doi:10.1007\/s00134-004-2525-9","DOI":"10.1007\/s00134-004-2525-9"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"21. Hendriks HG, Meijer K, de Wolf JT, et al. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study. Transplantation. 2001;71(3):402-405. doi:10.1097\/00007890-200102150-00011","DOI":"10.1097\/00007890-200102150-00011"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"22. Lodge JP, Jonas S, Jones RM, et al. Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation. Liver Transpl. 2005;11(8):973-979. doi:10.1002\/lt.20470","DOI":"10.1002\/lt.20470"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"23. Pugliese F, Ruberto F, Summonti D, et al. Activated recombinant factor VII in orthotopic liver transplantation. Transplant Proc. 2007;39(6):1883-1885. doi:10.1016\/j.transproceed.2007.05.062","DOI":"10.1016\/j.transproceed.2007.05.062"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"24. Kalicinski P, Markiewicz M, Kaminski A, et al. Single pretransplant bolus of recombinant activated factor VII ameliorates influence of risk factors for blood loss during orthotopic liver transplantation. Pediatr Transplant. 2005;9(3):299-304. doi:10.1111\/j.1399-3046.2005.00309.x","DOI":"10.1111\/j.1399-3046.2005.00309.x"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"25. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365(2):147-156. doi:10.1056\/NEJMra1011170","DOI":"10.1056\/NEJMra1011170"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"26. Stuart EA. Matching methods for causal inference: A review and a look forward. Stat Sci. 2010;25(1):1-21. doi:10.1214\/09-STS313","DOI":"10.1214\/09-STS313"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T08:13:37Z","timestamp":1664352817000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/archive\/2022\/20\/9\/0\/817\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2022.0159","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}